ID   L-M(BU-25)
AC   CVCL_DE17
SY   L-M (BU-25); LM BU25
DR   Wikidata; Q54900902
RX   PubMed=14033130;
RX   PubMed=14056989;
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4535 ! L-M
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
RX   PubMed=14033130; DOI=10.1016/0042-6822(62)90015-6;
RA   Kit S., Dubbs D.R.;
RT   "Biochemistry of vaccinia-infected mouse fibroblasts (strain L-M). II.
RT   Properties of the chromosomal DNA of infected cells.";
RL   Virology 18:286-293(1962).
//
RX   PubMed=14056989; DOI=10.1016/0014-4827(63)90007-7;
RA   Kit S., Dubbs D.R., Piekarski L.J., Hsu T.-C.;
RT   "Deletion of thymidine kinase activity from L cells resistant to
RT   bromodeoxyuridine.";
RL   Exp. Cell Res. 31:297-312(1963).
//